Delighted to welcome Leanne Antido, who has just started their MSc by Research in the group. Co-supervised by myself and Dr Nick Robinson. Leanne’s project focuses on discovering #antibodies against #Asgard #archaeal proteins and developing them as tools to study protein function

🚨 Funded PhD Studentship 🚨 Antibody Engineering & Plant Molecular Farming for Aquaculture Health 📍 Lancaster & Glasgow | BBSRC NWBio DTP 🗓 Apply by 21 Nov 2025 👉 Engineer antibodies vs Vibrio 👉 Develop rapid diagnostics 👉 Explore plant-based biologics for fish health

Stef Menzies @menzieslab.bsky.social @blslancasteruni.bsky.social is leading a project with Martin Llewellyn (Glasgow) and I looking at antibody engineering and different ways to deliver these in aquaculture settings, including some plant engineering! www.gla.ac.uk/postgraduate...

Another paper hot off the press! Dual proteomics strategies to characterise and compare the venom composition of nine African #snake #venoms . A wonderful collaboration with Louc Quinton's lab as part of the ADDovenom project. @blslancasteruni.bsky.social 🐍🧪 www.mdpi.com/2072-6651/17...

A new snake antivenom serum in Brazil is three times more effective than the current standard, with reduced adverse effects, potentially improving treatment for Bothrops envenomation. doi.org/g9fnm9

Our review article on progress towards #recombinant #antivenoms for #snakebite is now published at www.tandfonline.com/doi/full/10.... We cover snakebite, methods for #mAb discovery, do a deep dive on mAbs for neurotoxins, and discuss what is needed next to get this from concept to clinic.

Last week I had the great pleasure in hosting the launch meeting of our NC3Rs project grant now known as G.E.M (Galleria Envenoming Model). Our work is focused on developing and validating an alternative model to assess venom lethality and therapeutic efficacy testing.

Our department now hosts two labs with interests in #snakebite – Steve Hall Lab and @menzieslab.bsky.social. Snakebite is a global health crisis that affects millions annually. Conventional antivenom, the only currently available treatment, has severe limitations. #WorldNTDDay #BeatNTDs (1/3)

First post on BlueSky - sharing our latest paper! So thrilled to have been part of this exciting collaboration - using AI to design new protein-based therapeutics for #snakebite 🐍 www.nature.com/articles/s41...